Preoperative erythropoietin in spine surgery

  • Maria J. Colomina
  • Carmen Godet
  • Juan Bagó
  • Ferran Pellisé
  • Carlos Villanueva


Spine surgery may be associated with profuse intraoperative bleeding that often requires blood transfusions. In recent years several techniques have been developed to avoid allogenic transfusions and their potential complications to surgical patients. In this study we review and analyse the role of preoperative recombinant human erythropoietin (rHuEPO) administration in spine surgery as a blood conservation strategy. Between 1998 and 2002, a total of 250 patients scheduled for spine surgery were included in our bloodsparing program: 114 patients (group 1), operated on before rHuEPO approval (2000), underwent preoperative autologous blood donation (ABD) alone, and 136 patients operated on after rHuEPO approval (groups 2 and 3) received rHuEPO while undergoing ABD. Adding rHuEPO to ABD resulted in higher haemoglobin and haematocrit values the day of surgery, more ABD units retrieved per patient and, consequently, reduced allogenic transfusion requirements. The effectiveness of rHuEPO as the only preoperative blood conservation technique was evaluated in ten patients with a predicted blood loss of less than 30% of their total volume, scheduled for lumbar surgery. Data from these patients were matched with those from a similar group of patients who had undergone ABD. Patients receiving rHuEPO alone had higher haemoglobin levels the day of surgery than did patients in the ABD program. Neither group required allogenic transfusions. Conclusions: preoperative rHuEPO is useful for reducing allogenic blood requirements in elective spine surgery. In patients with an expected blood loss of around 50% of blood volume, rHuEPO improves ABD, minimising preoperative anaemia and increasing the number of ABD units collected. In patients with expected blood loss below 30% of total volume, rHuEPO administration may replace ABD.


Erythropoietin Spine surgery Autologous donation Perioperative bleeding Blood-sparing technique 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abildgaard L, Aaro S, Lisander B (2001) Limited effectiveness of intraoperative autotransfusion in major back surgery. Eur J Anaesthesiol 18:823–828Google Scholar
  2. 2.
    Alanay A, Acaroglu E, Ozdemir O, Ercelen O, Bulutcu E, Surat A (1999) Effects of deamino-8-D-arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A doubleblind randomized clinical trial. Spine 24:877–882CrossRefPubMedGoogle Scholar
  3. 3.
    Anand N, Idio FG Jr., Remer S, Hoppenfeld S (1998) The effects of perioperative blood salvage and autologous blood donation on transfusion requirements in scoliosis surgery. J Spinal Disord 11:532–534PubMedGoogle Scholar
  4. 4.
    Audet AM, Goodnough LT, Parvin CA (1996) Evaluating the appropriateness of red blood cell transfusions: the limitations of retrospective medical record reviews. Int J Qual Health Care 8:41–49CrossRefPubMedGoogle Scholar
  5. 5.
    Beris P (1996) Epoetin alfa as an adjuvant to autologous blood donation. Semin Hematol 33:27–29PubMedGoogle Scholar
  6. 6.
    Beris P (1996) Epoetin alfa: new directions in orthopedic surgery. Semin Hematol 33:60–62PubMedGoogle Scholar
  7. 7.
    Beris P, Mermillod B, Levy G, Laubriat M, Soulier-Lauper M, Tullen E, Hugli A, Miescher PA (1993) Recombinant human erythropoietin as adjuvant treatment for autologous blood donation. A prospective study. Vox Sang 65:212–218PubMedGoogle Scholar
  8. 8.
    Blumberg N (1997) Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol 34:34–40Google Scholar
  9. 9.
    Bose WJ (1996) The potential use of human recombinant erythropoietin in orthopedic surgery. Orthopedics 19: 325–328PubMedGoogle Scholar
  10. 10.
    Browne JK, Cohen AM, Egrie JC, Lai PH, Lin FK, Strickland T, Watson E, Stebbing N (1986) Erythropoietin: gene cloning, protein structure, and biological properties. Cold Spring Harb Symp Quant Biol 51 Pt 1:693–702PubMedGoogle Scholar
  11. 11.
    Cha CW, Deible C, Muzzonigro T, Lopez-Plaza I, Vogt M, Kang JD (2002) Allogeneic transfusion requirements after autologous donations in posterior lumbar surgeries. Spine 27: 99–104CrossRefPubMedGoogle Scholar
  12. 12.
    Cheung W, Minton N, Gunawardena K (2001) Pharmacokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly. Eur J Clin Pharmacol 57:411–418CrossRefPubMedGoogle Scholar
  13. 13.
    Cheung WK, Natarajan J, Sanders M, Vercammen E (2000) Comparative pharmacokinetics, safety, and tolerability after subcutaneous administration of recombinant human erythropoietin formulated with different stabilizers. Biopharm Drug Dispos 21:211–219CrossRefPubMedGoogle Scholar
  14. 14.
    Copley LA, Richards BS, Safavi FZ, Newton PO (1999) Hemodilution as a method to reduce transfusion requirements in adolescent spine fusion surgery. Spine 24:219–222CrossRefPubMedGoogle Scholar
  15. 15.
    de Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M, Young DC (1996) Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop 25:533–542CrossRefPubMedGoogle Scholar
  16. 16.
    de Andrade JR, Frei D, Guilfoyle M (1999) Integrated analysis of thrombotic/vascular event occurrence in epoetin alfa-treated patients undergoing major, elective orthopedic surgery. Orthopedics 22:s113–s118PubMedGoogle Scholar
  17. 17.
    de Pree C, Mermillod B, Hoffmeyer P, Beris P (1997) Recombinant human erythropoietin as adjuvant treatment for autologous blood donation in elective surgery with large blood needs (>or=5 units): a randomized study. Transfusion 37:708–714CrossRefPubMedGoogle Scholar
  18. 18.
    Dorsey AT, Schwartz RE, Stayer SA, Pasquariello CA (1993) Scoliosis surgery: determinants of blood loss. Anesth Analg 76:684–685PubMedGoogle Scholar
  19. 19.
    Du TG, Relton JE, Gillespie R (1978) Acute haemodilutional autotransfusion in the surgical management of scoliosis. J Bone Joint Surg Br 60:178–180PubMedGoogle Scholar
  20. 20.
    Egrie JC, Strickland TW, Lane J, Aoki K, Cohen AM, Smalling R, Trail G, Lin FK, Browne JK, Hines DK (1986) Characterization and biological effects of recombinant human erythropoietin. Immunobiology 172:213–224PubMedGoogle Scholar
  21. 21.
    Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW (1991) The safety of epoetin-alpha: results of clinical trials in the United States. Contrib Nephrol 88:72–80PubMedGoogle Scholar
  22. 22.
    Faris P (1996) Use of recombinant human erythropoietin in the perioperative period of orthopedic surgery. Am J Med 101:28S–32SCrossRefPubMedGoogle Scholar
  23. 23.
    Faris PM, Ritter MA, Abels RI (1996) The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J Bone Joint Surg Am 78:62–72PubMedGoogle Scholar
  24. 24.
    Faris PM, Spence RK, Larholt KM, Sampson AR, Frei D (1999) The predictive power of baseline hemoglobin for transfusion risk in surgery patients. Orthopedics 22:s135–s140PubMedGoogle Scholar
  25. 25.
    Feeley TW, Rinsky LA (1993) Use of aprotinin to reduce intraoperative bleeding. West J Med 159:189–192PubMedGoogle Scholar
  26. 26.
    Fievez E, Schultze-Balin C, Herbaux B, Dalmas S, Scherpereel P (1995) [A study of blood loss during surgery for scoliosis. Posterior approach in 319 adolescents]. Cah Anesthesiol 43:425–433PubMedGoogle Scholar
  27. 27.
    Florentino-Pineda I, Blakemore LC, Thompson GH, Poe-Kochert C, Adler P, Tripi P (2001) The Effect of epsilon-aminocaproic acid on perioperative blood loss in patients with idiopathic scoliosis undergoing posterior spinal fusion: a preliminary prospective study. Spine 26:1147–1151CrossRefPubMedGoogle Scholar
  28. 28.
    Gaudiche O, Loose JP, Egu JF, Dubousset J, Saint-Maurice C (1988) [Autotransfusion using Cell Saver III. Experience with 90 cases of surgery of the spine in childhood and adolescence]. Cah Anesthesiol 36:451–457PubMedGoogle Scholar
  29. 29.
    Goldberg MA (1995) Erythropoiesis, erythropoietin, and iron metabolism in elective surgery: preoperative strategies for avoiding allogeneic blood exposure. Am J Surg 170:37S–43SCrossRefPubMedGoogle Scholar
  30. 30.
    Goldberg MA (1997) Perioperative epoetin alfa increases red blood cell mass and reduces exposure to transfusions: results of randomized clinical trials. Semin Hematol 34:41–47PubMedGoogle Scholar
  31. 31.
    Goldberg MA, McCutchen JW, Jove M, Di Cesare P, Friedman RJ, Poss R, Guilfoyle M, Frei D, Young D (1996) A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 25:544–552PubMedGoogle Scholar
  32. 32.
    Goodnough LT (1990) Erythropoietin as a pharmacologic alternative to blood transfusion in the surgical patient. Transfus Med Rev 4:288–296PubMedGoogle Scholar
  33. 33.
    Goodnough LT (1993) The role of recombinant growth factors in transfusion medicine. Br J Anaesth 70:80–86PubMedGoogle Scholar
  34. 34.
    Goodnough LT (1994) The implications of cost-effectiveness for autologous blood procurement. Arch Pathol Lab Med 118:333–334PubMedGoogle Scholar
  35. 35.
    Goodnough LT (1994) The safety of recombinant human erythropoietin therapy in autologous blood donors. J Lab Clin Med 124:17–18PubMedGoogle Scholar
  36. 36.
    Goodnough LT (1996) Current red blood cell transfusion practices. AACN Clin Issues 7:212–220CrossRefPubMedGoogle Scholar
  37. 37.
    Goodnough LT, Brecher ME (1998) Autologous blood transfusion. Intern Med 37:238–245PubMedGoogle Scholar
  38. 38.
    Goodnough LT, Brittenham GM (1990) Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs. J Lab Clin Med 115:28–35PubMedGoogle Scholar
  39. 39.
    Goodnough LT, Marcus RE (1992) Effect of autologous blood donation in patients undergoing elective spine surgery. Spine 17:172–175PubMedGoogle Scholar
  40. 40.
    Goodnough LT, Shuck JM (1990) Risks, options, and informed consent for blood transfusion in elective surgery. Am J Surg 159:602–609PubMedGoogle Scholar
  41. 41.
    Goodnough LT, Rudnick S, Price TH, Ballas SK, Collins ML, Crowley JP, Kosmin M, Kruskall MS, Lenes BA, Menitove JE, (1989) Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 321:1163–1168PubMedGoogle Scholar
  42. 42.
    Goodnough LT, Wasman J, Corlucci K, Chernosky A (1989) Limitations to donating adequate autologous blood prior to elective orthopedic surgery. Arch Surg 124:494–496PubMedGoogle Scholar
  43. 43.
    Goodnough LT, Price TH, Rudnick S, Soegiarso RW (1992) Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy. Transfusion 32:441–445CrossRefPubMedGoogle Scholar
  44. 44.
    Goodnough LT, Price TH, Friedman KD, Johnston M, Ciavarella D, Khan N, Sacher R, Vogler WR, Wissel M, Abels RI (1994) A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. Transfusion 34:66–71CrossRefPubMedGoogle Scholar
  45. 45.
    Goodnough LT, Strasburg D, Riddell J, Verbrugge D, Wish J (1994) Has recombinant human erythropoietin therapy minimized red-cell transfusions in hemodialysis patients? Clin Nephrol 41:303–307PubMedGoogle Scholar
  46. 46.
    Goodnough LT, Verbrugge D, Marcus RE, Goldberg V (1994) The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell volume expansion in autologous blood donors for elective orthopedic operation. J Am Coll Surg 179: 171–176PubMedGoogle Scholar
  47. 47.
    Goodnough LT, Vizmeg K, Verbrugge D (1994) The impact of autologous blood ordering and blood procurement practices on allogeneic blood exposure in elective orthopedic surgery patients. Am J Clin Pathol 101:354–357PubMedGoogle Scholar
  48. 48.
    Goodnough LT, Monk TG, Andriole GL (1997) Erythropoietin therapy. N Engl J Med 336:933–938CrossRefPubMedGoogle Scholar
  49. 49.
    Hansen E, Pollwein B, Martin E, Heim MU, Horst S, Matzen KA, Peter K (1987) [Autologous transfusion in scoliosis operations: preoperative autologous blood donations and intraoperative mechanical autotransfusion]. Z Orthop Ihre Grenzgeb 125:262–267PubMedGoogle Scholar
  50. 50.
    Keating EM, Meding JB (2002) Perioperative blood management practices in elective orthopaedic surgery. J Am Acad Orthop Surg 10:393–400PubMedGoogle Scholar
  51. 51.
    Keating M, Faris P, Ritter M (1998) Erythropoietin use. Orthopedics 21:13–14PubMedGoogle Scholar
  52. 52.
    Kosmadakis N, Messaris E, Maris A, Katsaragakis S, Leandros E, Konstadoulakis MM, Androulakis G (2003) Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: prospective randomized double-blind study. Ann Surg 237:417–421CrossRefPubMedGoogle Scholar
  53. 53.
    Laupacis A (1996) Effectiveness of perioperative epoetin alfa in patients scheduled for elective hip surgery. Semin Hematol 33:51–53PubMedGoogle Scholar
  54. 54.
    Lee JH, Lee SH, Oh JH (2003) Minimal effective dosage of recombinant human erythropoietin in spinal surgery. Clin Orthop 71–76Google Scholar
  55. 55.
    Levine EA, Gould SA, Rosen AL, Sehgal LR, Egrie JC, Sehgal HL, Levine HD, Moss GS (1989) Perioperative recombinant human erythropoietin. Surgery 106:432–437PubMedGoogle Scholar
  56. 56.
    Lisander B, Jonsson R, Nordwall A (1996) Combination of blood-saving methods decreases homologous blood requirements in scoliosis surgery. Anaesth Intensive Care 24:555–558PubMedGoogle Scholar
  57. 57.
    MacEwen GD, Bennett E, Guille JT (1990) Autologous blood transfusions in children and young adults with low body weight undergoing spinal surgery. J Pediatr Orthop 10:750–753PubMedGoogle Scholar
  58. 58.
    McCall RE, Bilderback KK (1997) Use of intravenous Premarin to decrease postoperative blood loss after pediatric scoliosis surgery. Spine 22:1394–1397CrossRefPubMedGoogle Scholar
  59. 59.
    McNeill TW, DeWald RL, Kuo KN, Bennett EJ, Salem MR (1974) Controlled hypotensive anesthesia in scoliosis surgery. J Bone Joint Surg Am 56:1167–1172PubMedGoogle Scholar
  60. 60.
    Mercuriali F, Inghilleri G (1998) [Blood transfusion in oncologic surgery: the role of recombinant human erythropoietin (rHuEPO)]. Tumori 84:S3–14Google Scholar
  61. 61.
    Mercuriali F, Zanella A, Barosi G, Inghilleri G, Biffi E, Vinci A, Colotti MT (1993) Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 33:55–60CrossRefPubMedGoogle Scholar
  62. 62.
    Mercuriali F, Inghilleri G, Biffi E, Colotti MT, Vinci A, Scalamogna R, Zanella A (1994) Erythropoietin treatment to increase autologous blood donation in patients with low basal hematocrit undergoing elective orthopedic surgery. Clin Investig 72:S16–S18PubMedGoogle Scholar
  63. 63.
    Mercuriali F, Inghilleri G, Biffi E (2000) New approach to preoperative autologous blood donation (PABD). Int J Artif Organs 23:221–231PubMedGoogle Scholar
  64. 64.
    Murray DJ, Forbes RB, Titone MB, Weinstein SL (1997) Transfusion management in pediatric and adolescent scoliosis surgery. Efficacy of autologous blood. Spine 22:2735–2740CrossRefPubMedGoogle Scholar
  65. 65.
    Neilipovitz DT, Murto K, Hall L, Barrowman NJ, Splinter WM (2001) A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg 93:82–87CrossRefPubMedGoogle Scholar
  66. 66.
    Nuttall GA, Horlocker TT, Santrach PJ, Oliver WCJ, Dekutoski MB, Bryant S (2000) Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine 25:596–601CrossRefPubMedGoogle Scholar
  67. 67.
    Olsfanger D, Jedeikin R, Metser U, Nusbacher J, Gepstein R (1993) Acute normovolaemic haemodilution and idiopathic scoliosis surgery: effects on homologous blood requirements. Anaesth Intensive Care 21:429–431PubMedGoogle Scholar
  68. 68.
    Phillips WA, Hensinger RN (1988) Control of blood loss during scoliosis surgery. Clin Orthop 88–93Google Scholar
  69. 69.
    Price TH, Goodnough LT, Vogler WR, Sacher RA, Hellman RM, Johnston MF, Bolgiano DC, Abels RI (1996) Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin. Am J Med 101:22S–27SCrossRefGoogle Scholar
  70. 70.
    Price TH, Goodnough LT, Vogler WR, Sacher RA, Hellman RM, Johnston MF, Bolgiano DC, Abels RI (1996) The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trial. Transfusion 36:29–36CrossRefPubMedGoogle Scholar
  71. 71.
    Quirt I, Robeson C, Lau CY, Kovacs M, Burdette-Radoux S, Dolan S, Tang SC, McKenzie M, Couture F (2001) Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy. J Clin Oncol 19:4126–4134PubMedGoogle Scholar
  72. 72.
    Rosencher N, Conseiller C (2001) [Autologous blood transfusion]. Rev Prat 51:1328–1331PubMedGoogle Scholar
  73. 73.
    Rosencher N, Ozier Y (2003) [Peri-operative use of EPO]. Transfus Clin Biol 10:159–164CrossRefPubMedGoogle Scholar
  74. 74.
    Rosencher N, Woimant G, Ozier Y, Conseiller C (1999) [Preoperative strategy for homologous blood salvage and peri-operative erythropoietin]. Transfus Clin Biol 6:370–379CrossRefPubMedGoogle Scholar
  75. 75.
    Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL (2003) Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 43:459–469CrossRefPubMedGoogle Scholar
  76. 76.
    Roye DP Jr (1999) Recombinant human erythropoietin and blood management in pediatric spine surgery. Orthopedics 22:s158–s160PubMedGoogle Scholar
  77. 77.
    Roye DP Jr, Rothstein P, Rickert JB, Verdisco L, Farcy JP (1992) The use of preoperative erythropoietin in scoliosis surgery. Spine 17:S204–S205PubMedGoogle Scholar
  78. 78.
    Sculco TP (1995) Blood management in orthopedic surgery. Am J Surg 170:60S–63SCrossRefPubMedGoogle Scholar
  79. 79.
    Shapiro GS, Boachie-Adjei O, Dhawlikar SH, Maier LS (2002) The use of epoetin alfa in complex spine deformity surgery. Spine 27:2067–2071CrossRefPubMedGoogle Scholar
  80. 80.
    Siller TA, Dickson JH, Erwin WD (1996) Efficacy and cost considerations of intraoperative autologous transfusion in spinal fusion for idiopathic scoliosis with predeposited blood. Spine 21:848–852CrossRefPubMedGoogle Scholar
  81. 81.
    Stehling L, Luban NL, Anderson KC, Sayers MH, Long A, Attar S, Leitman SF, Gould SA, Kruskall MS, Goodnough LT (1994) Guidelines for blood utilization review. Transfusion 34:438–448CrossRefPubMedGoogle Scholar
  82. 82.
    Stowell CP, Chandler H, Jove M, Guilfoyle M, Wacholtz MC (1999) An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty. Orthopedics 22:s105–s112PubMedGoogle Scholar
  83. 83.
    Sum DC, Chung PC, Chen WC (1996) Deliberate hypotensive anesthesia with labetalol in reconstructive surgery for scoliosis. Acta Anaesthesiol Sin 34: 203–207PubMedGoogle Scholar
  84. 84.
    Thomas MJ, Gillon J, Desmond MJ (1996) Consensus conference on autologous transfusion. Preoperative autologous donation. Transfusion 36:633–639CrossRefPubMedGoogle Scholar
  85. 85.
    Urban MK, Beckman J, Gordon M, Urquhart B, Boachie-Adjei O (2001) The efficacy of antifibrinolytics in the reduction of blood loss during complex adult reconstructive spine surgery. Spine 26:1152–1156CrossRefPubMedGoogle Scholar
  86. 86.
    Vitale MG, Stazzone EJ, Geljins AC, Moskowitz AJ, Roye DP Jr (1998) The effectiveness of preoperative erythropoietin in averting allogenic blood transfusion among children undergoing scoliosis surgery. J Pediatr Orthop B:166–172Google Scholar
  87. 87.
    Vitale MG, Levy DE, Park MC, Choi H, Choe JC, Roye DP, Jr. (2002) Quantifying risk of transfusion in children undergoing spine surgery. Spine J 2:166–172CrossRefPubMedGoogle Scholar
  88. 88.
    Viviani GR, Sadler JT, Ingham GK (1978) Autotransfusions in scoliosis surgery. Review of 20 Harrington fusions. Clin Orthop 74–78Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Maria J. Colomina
    • 1
    • 2
  • Carmen Godet
    • 1
  • Juan Bagó
    • 3
  • Ferran Pellisé
    • 3
  • Carlos Villanueva
    • 3
  1. 1.Department of AnaesthesiologyHospital Universitario Vall d’HebronBarcelonaSpain
  2. 2.BarcelonaSpain
  3. 3.Department of Spine SurgeryHospital Universitario Vall d’HebronBarcelonaSpain

Personalised recommendations